Table 3 Clinical response according to the genotype of TP53 SNP rs1042522
Response | Genotype | P | |
|---|---|---|---|
|  | GG + GC (%) | CC (%) | |
All patients | |||
 CR | 196(61) | 33(44) | 0.007 |
 PR + PD + SD | 125(38.9) | 42(56) | |
 OR | 276(86) | 57(76) | 0.033 |
 PD + SD | 45(14) | 18(24) | |
Patients without Rituximab | |||
 CR | 38(45.8) | 3(12.5) | 0.004a |
 PR + PD + SD | 45(54.2) | 21(87.5) | |
 OR | 69(83.1) | 18(75) | 0.368 |
 PD + SD | 14(16.9) | 6(25) | |
Patients with Rituximab | |||
 CR | 158(66.4) | 30(58.8) | 0.304 |
 PR + PD + SD | 80(33.6) | 21(41.2) | |
 OR | 207(87) | 39(76.5) | 0.056 |
 PD + SD | 31(13) | 12(23.5) | |